Abstract
Following an application from Nutrilinks Sarl submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Cyprus, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to ♀EFAX™ and reduction of menstrual discomfort. The food, ♀EFAX™, which is standardised pure krill oil and is the subject of the health claim, is sufficiently characterised. The claimed effect, reduction of menstrual discomfort, is a beneficial physiological effect. No human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. A cause and effect relationship has not been established between the consumption of ♀EFAX™ and reduction of menstrual discomfort.
© European Food Safety Authority, 2013
© European Food Safety Authority, 2013
Original language | English |
---|
Place of Publication | Parma, Italy |
---|---|
Publisher | European Food Safety Authority |
Number of pages | 9 |
DOIs | |
Publication status | Published - 2013 |
Series | EFSA Journal |
---|---|
Number | 2 |
Volume | 11 |
ISSN | 1830-5458 |
Bibliographical note
EFSA scientific opinion 2013EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Keywords
- ♀EFAX
- Krill oil
- Menstrual discomfort
- Health claims